SNX25P1

Across TCGA pan-cancer cohorts, SNX25P1 RNA is linked to patient survival in 24 of 34 cancer types, making it the most broadly survival-associated SNX25P1 data layer.

The strongest signal is observed in liver hepatocellular carcinoma (LIHC), where higher SNX25P1 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated SNX25P1 expression acts as an unfavorable survival marker, although some lineages such as THCA and PRAD show a favorable association.

LIHC, UVM, and KIRP are the cancer types where SNX25P1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LIHC	OS	Median	All	0.703	0.843	<.001	96	view →
UVM	DFS	Quartile	III,IV	0.216	0.914	.001	66	view →
KIRP	DFS	Median	All	0.784	0.919	<.001	42	view →
BLCA	DFS	Quartile	All	0.398	0.551	.004	34	view →
GBM	DFS	Median	All	0.189	0.318	<.001	27	view →
STAD	OS	Median	III,IV	0.542	0.711	.014	24	view →
THCA	OS	Median	All	1.000	0.830	.007	23	view →
CESC	DFS	Median	IV	0.299	0.668	.013	18	view →
LUAD	DFS	Tertile	All	0.678	0.830	.010	14	view →
PRAD	DFS	Tertile	All	0.936	0.853	.009	14	view →
OV	OS	Tertile	IV	0.747	0.452	.009	12	view →
UCEC	DFS	Tertile	III,IV	0.763	0.470	.019	12	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 24 lineages.

SNX25P1–LIHC (OS)

Open the LIHC breakdown →